您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2016, Vol. 54 ›› Issue (11): 32-35.doi: 10.6040/j.issn.1671-7554.0.2015.1217

• 临床医学 • 上一篇    下一篇

胸腔镜治疗联合尿激酶局部应用在急性包裹性胸腔积液中的疗效评价

闫迪,马卫霞,姜淑娟,石欣雨,王娜   

  1. 山东大学附属省立医院呼吸内科, 山东 济南 250021
  • 收稿日期:2015-12-03 出版日期:2016-11-10 发布日期:2016-11-10
  • 通讯作者: 姜淑娟. E-mail:shujuan-jiang@163.com E-mail:shujuan-jiang@163.com

Value of thoracoscope combined with urokinase treatment on loculated pleural effusion

YAN Di, MA Weixia, JIANG Shujuan, SHI Xinyu, WANG Na   

  1. Department of Respiratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2015-12-03 Online:2016-11-10 Published:2016-11-10

PDF (PC)

283

摘要： 目的 评价胸腔镜联合尿激酶胸腔内注射治疗急性包裹黏连性胸腔积液的疗效。 方法 急性包裹黏连性胸腔积液患者58例,按照处理方法不同分为治疗组(n=27)、对照组(n=31),治疗组采用胸腔镜检查、治疗后放置胸腔闭式引流管,同时给予胸腔内注入尿激酶(10万U)保留24~48 h后引流,每周2次(可根据引流液的颜色增减次数);对照组常规胸腔置管引流。比较两组患者胸腔积液的引流量、积液蛋白含量、积液消失时间、胸膜厚度、治疗效果及并发症发生率。 结果 治疗组胸腔积液引流量为(1141.51±411.66)mL,显著多于对照组(751.93±605.53)mL(P<0.05);治疗组胸腔积液消失时间和胸膜厚度分别为(6.18±1.88)d和(2.09±0.50)mm,低于对照组(7.54±2.28)d和(2.90±0.57)mm(P<0.05);治疗组胸腔积液蛋白含量为(26.45±12.09)g,显著低于对照组(34.33±10.99)g(P<0.05)。治疗组有效率为96.3%(95%CI:58.5%~100%),高于对照组77.4%(95%CI:41.3%~100%)(P<0.001)。在并发症的发生率上两组差异无统计学意义(P>0.05)。 结论 内科胸腔镜联合尿激酶治疗包裹黏连性胸腔积液,患者胸腔积液引流量多、引流彻底、干净,积液消失快,胸膜增厚减轻,治疗效果好,且并发症无明显增加。

关键词: 包裹黏连性胸腔积液, 尿激酶, 胸腔镜

Abstract: Objective To evaluate the value of medical thoracoscope combined with urokinase treatment on loculated pleural effusion. Methods Fifty-eight patients with loculated pleural effusion were recruited and divided into the treatment group(n=27)and the control group(n=31). The treatment group was treated with medical thoracoscope and urokinase(1×105 U, twice a week)while the control group was given routine drainage. The total drainage volume, pleural thickness, protein content of pleural effusion, duration of pleural effusion, incidence of complication and therapeutic effect were compared. Results The total drainage volume in the treatment group was higher than that in the control group［(1141.51±411.66)vs(751.93±605.53)mL, P<0.05］; duration of the pleural effusion, pleural thickness and protein content of pleural effusion in the treatment group were lower than those in the control group［(6.18 ±1.88)vs(7.54±2.28)days,(2.09±0.50)vs(2.90±0.57)mm,(26.45 ±12.09)vs(34.33±10.99)g, all P<0.05］; medical effective rate in treatment group was higher than that in the control group(96.3% vs 77.4%, P<0.001). The incidence of complications in the two groups had no significant difference(P>0.05). Conclusion The value of the medical thoracoscopy combined with urokinase treatment on loculated pleural effusion is significant. The pleural effusion is drained thoroughly and rapidly. This method can increase the duration of the pleural effusion, relieve pleural thickening, and cause no obvious increase in complications.

Key words: Urokinase, Thoracoscope, Loculated pleural effusion

中图分类号: 

  • R561.6
[1] Letheulle J, Kerjouan M, Bénézit F, et al. Parapneumonic pleural effusions: epidemiology,diagnosis, classification and management[J]. Rev Mal Respir, 2015, 32(4): 344-357.
[2] Villena Garrido V, Cases Viedma E, Fernández Villar A, et al. Recommendations of diagnosis and treatment of pleural effusion[J]. Arch Bronconeumol, 2014, 50(6): 235-249.
[3] Rosenberg J, Herman SD, Smith PR, et al. Video-assisted thoracoscopic decortication of trapped lung in a patient with yellow nail Syndrome[J]. J Bronchology Interv Pulmonol, 2014, 21(1): 103-105.
[4] 吴社谋,董刚,张继红,等. 超声引导下穿刺治疗包裹性胸腔积液临床分析[J].中华实用诊断与治疗杂志,2013, 27(5): 508-510.
[5] Fletcher MA, Schmitt HJ, Syrochkina M, et al. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology[J]. Eur J Clin Microbiol Infect Dis, 2014, 33(6): 879-910.
[6] 苏莉莉,贾(龙)/天婷,姜淑娟. 尿激酶在包裹性脓胸中的应用[J].山东医药,2006, 4(14): 46-47.
[7] Nattusamy L, Madan K, Mohan A, et al. Utility of semi-rigid thoracoscopy in undiagnosed exudative pleural effusion[J]. Lung India, 2015, 32(2): 119-126.
[8] 瞿章书,徐小平,杨荣强,等.尿激酶胸腔内注射治疗包裹性胸腔积液31例[J].中华结核与呼吸杂志,2004, 27(4): 284-285.
[9] 童朝辉,王臻,徐莉莉,等. 可弯曲电子内科胸腔镜在不明原因胸腔积液诊断中的应用[J].中华结核和呼吸杂志,2007, 30(7): 533-537. TONG Zhaohui, WANG Zhen, XU Lili, et al. The application of flexirigid thoracoscopy in the diagnosis of pleural effusions with unknown aetiology[J]. Chin J Tuberc Respir Dis, 2007, 30(7): 533-537.
[10] Whitworth JM, Schneider KE, Fauci JM, et al. Outcomes of patients with gynecologic malignancies undergoing video-assisted thoracoscopic surgery(VATS)and pleurodesis for malignant pleural effusion[J]. Gynecol Oncol, 2012, 125(3): 646-648.
[11] Mineo TC, Sellitri F, Tacconi F, et al. Quality of life and outcomes after non intubated versus intubated video-thoracoscopic pleurodesis for malignant pleural effusion: comparison by a case-matched study[J]. J Palliat Med, 2014, 17(7): 761-768.
[12] Liman ST, Elicora A, Topcu S, et al. Value of autofluorescence in video-assisted thoracoscopic surgery in pleural diseases[J]. Thorac Cardiovasc Surg, 2013, 61(4): 350-356.
[13] 李成俊,张娟,门正昆,等. 胸腔镜介导下高频电刀辅助治疗结核性包裹性胸腔积液[J].中国防痨杂志,2013, 35(5): 393-394.
[14] Stefanutti G, Ghirardo V, Barbato A, et al. Evaluation of apediatric protocol of intrapleural urokinase for pleural empyema: a prospective study[J]. Surgery, 2010, 148(3): 589-594.
[15] 朱贵朝. 肝素或不同剂量尿激酶对结核包裹性胸腔积液临床疗效的对比研究[J].中华肺部疾病杂志(电子版), 2012, 5(1): 41-45. ZHU Guichao. Clinical comparative study on different doses of heparin or urokinase in the treatment of tuberculosis encysted pleural effusion[J]. Chin J Lung Dis(Electronic Edition), 2012, 5(1): 41-45.
[16] Bianchini MA, Ceccarelli PL, Repetto P, et al. Once-daily intrapleural urokinase treatment of complicatedparapneumonic effusion in pediatric patients[J]. Turk J Pediatr, 2010, 52(3): 274-277.
[17] de Benedictis FM, De Giorgi G, Niccoli A, et al. Treatment of complicated pleural effusion with intracavitary urokinase in children[J]. Pediatr Pulmonol, 2000, 29(6): 438-442.
[18] Montero Ruiz E, Daguerre Talou M, López Alvarez J, et al. Treatment of empyema and complicated pleural effusion with intrapleural fibrinolysis[J]. Med Clin(Barc), 2003, 121(3): 98-99.
[19] 姜淑娟,牟晓燕,张嵩,等. 内科胸腔镜术对不明原因胸腔积液的诊断价值[J]. 中华结核和呼吸杂志,2013, 36(5): 337-340. JIANG Shujuan, MU Xiaoyan, ZHANG Song, et al. The diagnostic value of medical thoracoscopy for unexplained pleural effusion[J]. Chin J Tuberc Respir Dis, 2013, 36(5): 337-340.
[20] 厉银平,刘桂霞,彭清臻,等. 内科胸腔镜结合尿激酶治疗结核性包裹性胸腔积液的临床应用[J].临床肺科杂志,2012, 17(9): 1621-1623. LI Yinping, LIU Guixia, PENG Qingzhen, et al. Application research of medical thoracoscopy combined with urokinase in the treatment of encapsulated tuberculous pleural effusion[J]. Journal of Clinical Pulmonary Medicine, 2012, 17(9): 1621-1623.
[21] 郭明,胡蒙,雷云宏. 胸腔镜配合尿激酶胸腔内注射治疗结核性包裹性胸腔积液[J].实用临床医学, 2008, 9(6): 57-58. GUO Ming, HU Meng, LEI Yunhong. Using video-assisted thoracoscopy and urokinase intrapleural injection in the treatment of pleural and tuburculous effusion[J]. Practical Clinical Medicine, 2008, 9(6): 57-58.
[1] 王成,刘庆华,赵娜,姚周虹,万云焱,林殿杰. 内科胸腔镜诊治曲菌性脓胸2例[J]. 山东大学学报（医学版）, 2017, 55(4): 107-110.
[2] 刘松涛,沈斌,林辉,李香伟,温昭科. 全胸腔镜下心脏不停跳与停跳二尖瓣置换术的对比[J]. 山东大学学报（医学版）, 2016, 54(8): 39-43.
[3] 王雯,刘尧,龙飞,马卫霞,苏莉莉. 外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系[J]. 山东大学学报（医学版）, 2016, 54(8): 72-77.
[4] 张春霞,邹存华,宋冬冬,余江. P38MAPK信号通路对卵巢癌中尿激酶型纤维蛋白酶原激活剂的影响[J]. 山东大学学报（医学版）, 2016, 54(2): 68-74.
[5] 习海波,傅龙龙,王共先,傅斌,李煜,宋小芬. 尿激酶3′-UTR 基因多态性与特发性草酸钙结石易感性的关系[J]. 山东大学学报(医学版), 2013, 51(5): 105-107.
[6] 张晶1，王春妮2，戚美2，王妍3，刘龙3，韩博2，3. 二烯丙三硫对乳腺癌MDA-MB-231细胞增殖和侵袭的抑制及对uPA系统的调节[J]. 山东大学学报(医学版), 2012, 50(10): 61-.
[7] 杜黎明，周朕，王曾，谢德荣. 内科胸腔镜治疗复杂性肺炎旁胸腔积液的研究[J]. 山东大学学报(医学版), 2010, 48(9): 82-.
[8] 崔纪云,林殿杰,马卫霞,龙成风,亓 梅,于学勇 . 结核性胸膜炎胸腔镜下表现[J]. 山东大学学报(医学版), 2008, 46(7): 733-734.
[9] 万兵,郑金旭,黄新建,严玉兰,吴建农 . 尿激酶对肺纤维化干预作用及对TGF-β1的影响[J]. 山东大学学报(医学版), 2007, 45(12): 1243-1246.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发